Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial

Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial
复制标题

外用皮质类固醇可减轻炎症而不影响光动力疗法治疗光化性角化病的疗效:一项随机临床试验

DOI:
--
复制
发表时间:
2014
影响因子:
10.3
通讯作者:
H. C. Wulf
H. C. Wulf
中科院分区:
医学1区
文献类型:
--
作者:
S. R. Wiegell;B. Petersen;H. C. Wulf

文献摘要

被引文献

相似文献

光动力疗法(PDT)是治疗光化性角化病(AK)和非黑色素瘤皮肤癌的有效和成熟的治疗方法。PDT的主要副作用是治疗后红斑和水肿以及照明期间的疼痛。PDT后严重的红斑增加了与治疗相关的停机时间。
Photodynamic therapy (PDT) is an effective and established treatment for actinic keratoses (AK) and nonmelanoma skin cancer. The main side‐effects of PDT are post‐treatment erythema and oedema, and pain during illumination. Severe erythema after PDT enhances the down time associated with the treatment.